Up Next
0
Pfizer's New Arthritis Drug
CNBC's Seema Mody reports on Pfizer ahead of the FDA advisory panel review of its rheumatoid arthritis drug.
Share
Pfizer's New Arthritis Drug
CNBC's Seema Mody reports on Pfizer ahead of the FDA advisory panel review of its rheumatoid arthritis drug.
Date: 5/7/12
Views: 146
Video by:  CNBC
 
Follow us:
Loading... 1 of 167
Today's Most Watched Videos
Related Videos
Loading... 1 of 56